These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1343799)

  • 1. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine.
    Calabrese KS; da Costa SC
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 1():49-56. PubMed ID: 1343799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
    Pratti JE; Ramos TD; Pereira JC; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; de Mello MF; Chaves SP; Gomes DC; Diaz BL; Rossi-Bergmann B; de Matos Guedes HL
    Parasit Vectors; 2016 Oct; 9(1):534. PubMed ID: 27716449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of mice against Leishmania mexicana amazonensis with microsomal fraction associated with BCG.
    Goncalves da Costa S; Santos EB; Lagrange PH
    Ann Inst Pasteur Immunol; 1988; 139(2):143-56. PubMed ID: 3370128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.
    Mora AM; Mayrink W; Costa RT; Costa CA; Genaro O; Nascimento E
    Rev Inst Med Trop Sao Paulo; 1999; 41(4):243-8. PubMed ID: 10564919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
    Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
    Armijos RX; Weigel MM; Calvopina M; Hidalgo A; Cevallos W; Correa J
    Vaccine; 2004 Mar; 22(9-10):1320-6. PubMed ID: 15003662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
    Connell ND; Medina-Acosta E; McMaster WR; Bloom BR; Russell DG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11473-7. PubMed ID: 8265576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection.
    de Matos Guedes HL; da Silva Costa BL; Chaves SP; de Oliveira Gomes DC; Nosanchuk JD; De Simone SG; Rossi-Bergmann B
    Parasit Vectors; 2014 Sep; 7():448. PubMed ID: 25239157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence.
    da Fonseca AL; Vallochi AL; Furtado Gde C; Abrahamsohn Ide A; Lima GM
    Parasitol Res; 1997; 83(7):690-7. PubMed ID: 9272560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice.
    de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS
    J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis.
    Terabe M; Wakana S; Katakura K; Onodera T; Matsumoto Y; Ito M
    Parasitol Int; 2004 Sep; 53(3):217-21. PubMed ID: 15468528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of a functional B cell germinal center response after Leishmania species co-infection is associated with lesion resolution.
    Gibson-Corley KN; Boggiatto PM; Bockenstedt MM; Petersen CA; Waldschmidt TJ; Jones DE
    Am J Pathol; 2012 May; 180(5):2009-17. PubMed ID: 22429963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and purification of immunogenic proteins from nonliving promastigote polyvalent Leishmania vaccine (Leishvacin ).
    Cardoso SR; da Silva JC; da Costa RT; Mayrink W; Melo MN; Michalick MS; Liu IA; Fujiwara RT; Nascimento E
    Rev Soc Bras Med Trop; 2003; 36(2):193-9. PubMed ID: 12806454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
    Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
    Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.